Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

PURPOSE: Accurate risk stratification can improve lymphoma management, but current volumetric (18)F-fluorodeoxyglucose (FDG) indicators require time-consuming segmentation of all lesions in the body. Herein, we investigated the prognostic values of readily obtainable metabolic bulk volume (MBV) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Hyun, Jin, Myung, Lim, Chae Hong, Choi, Joon Young, Kim, Seok-Jin, Lee, Kyung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293666/
https://www.ncbi.nlm.nih.gov/pubmed/37384292
http://dx.doi.org/10.3389/fonc.2023.1186311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293666/
https://www.ncbi.nlm.nih.gov/pubmed/37384292
http://dx.doi.org/10.3389/fonc.2023.1186311

Ejemplares similares